![]() |
Volumn 21, Issue 17, 2013, Pages 5561-5572
|
C-Glucosides with heteroaryl thiophene as novel sodium-dependent glucose cotransporter 2 inhibitors
|
Author keywords
Canagliflozin; Glucoside; SGLT2 inhibitor; Thiophene; Type 2 diabetes
|
Indexed keywords
1 [BETA DEXTRO GLUCOPYRANOSYL] 4 METHYL 3 [5 [2 PYRIMIDYL] 2 THIENYLMETHYL]BENZENE;
1 [BETA DEXTRO GLUCOPYRANOSYL] 4 METHYL 3 [5 [3 PYRIDYL] 2 THIENYLMETHYL]BENZENE;
1 [BETA DEXTRO GLUCOPYRANOSYL] 4 METHYL 3 [5 [5 PYRIMIDYL] 2 THIENYLMETHYL]BENZENE;
1 [BETA DEXTRO GLUCOPYRANOSYL] 4 METHYL 3 [5 [5 THIAZOLYL] 2 THIENYLMETHYL]BENZENE;
4 CHLORO 1 [BETA DEXTRO GLUCOPYRANOSYL] 3 [5 [2 PYRAZOL 1 YL] 2 THIENYLMETHYL]BENZENE;
4 CHLORO 1 [BETA DEXTRO GLUCOPYRANOSYL] 3 [5 [3 PYRIDYL] 2 THIENYLMETHYL]BENZENE;
4 CHLORO 3 [5[6 FLUORO 3 PYRIDYL] 2 THIENYLMETHYL] 1 [BETA DEXTRO GLUCOPYRANOSYL]BENZENE;
CANAGLIFLOZIN;
GLUCOSIDE;
PROTEIN INHIBITOR;
PYRIDINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
SODIUM DEPENDENT GLUCOSE COTRANSPORTER 2 INHIBITOR;
TA 3404;
THIOPHENE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIDIABETIC ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
DISTRIBUTION VOLUME;
DRUG CLEARANCE;
DRUG DESIGN;
DRUG HALF LIFE;
DRUG SYNTHESIS;
LIPID DIET;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
TIME TO MAXIMUM PLASMA CONCENTRATION;
MUS;
CANAGLIFLOZIN;
GLUCOSIDE;
SGLT2 INHIBITOR;
THIOPHENE;
TYPE 2 DIABETES;
ANIMALS;
BLOOD GLUCOSE;
CELL LINE;
CHO CELLS;
CRICETINAE;
CRICETULUS;
DIET, HIGH-FAT;
GLUCOSIDES;
HALF-LIFE;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MICE;
MONOSACCHARIDES;
PROTEIN BINDING;
PYRIDINES;
RATS;
RATS, SPRAGUE-DAWLEY;
SODIUM-GLUCOSE TRANSPORTER 1;
SODIUM-GLUCOSE TRANSPORTER 2;
THIOPHENES;
|
EID: 84881371173
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2013.05.048 Document Type: Article |
Times cited : (28)
|
References (21)
|